We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

9 hedge funds and large institutions have $1.53M invested in Stealth BioTherapeutics Corp. ADS in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more capital invested

Capital invested by funds: $947K → $1.53M (+$585K)

10% less funds holding

Funds holding: 10 → 9 (-1)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$233K
2
UBS Group
UBS Group
Switzerland
+$26.6K
3
HF
HRT Financial
New York
+$25.1K

Top Sellers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
-$82K
2
Millennium Management
Millennium Management
New York
-$25.6K
3
Two Sigma Investments
Two Sigma Investments
New York
-$15K
4
Deutsche Bank
Deutsche Bank
Germany
-$12K
5
PC
PA Capital
Virginia
-$1.96K

MITO Hedge Fund Activity: Q2 2020 in Review

9 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q2 2020, worth a combined $1.53M — up 62% from $947K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of MITO and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $233K. The largest seller was Prosight Management, cutting an estimated $82K.

  • 9 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q2 2020, down from 10 in Q1 2020.
  • Funds reported $1.53M of Stealth BioTherapeutics Corp. ADS stock for Q2 2020, up 62% quarter-over-quarter.
  • 1 fund opened new Stealth BioTherapeutics Corp. ADS positions in Q2 2020 and 2 closed out, a net change of -1 holder.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q2 2020 was Renaissance Technologies, an estimated $233K added.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q2 2020 was Prosight Management, an estimated $82K sold.

Based on aggregated 13F filings for Q2 2020.